Johnson & Johnson (JNJ)

ABD Holding Company, Inc. • ABIOMED COMMERCIAL, LLC • ABIOMED R&D, Inc. • ABIOMED, Inc. • Actelion Pharmaceuticals US, Inc. • Albany Street LLC • ALZA Corporation • Ambrx Biopharma, Inc. • Ambrx, Inc. • AMO Development, LLC ...

IRS number

221024240

JNJ stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$238.45

Low target

$208.00

High target

$265.00

Latest filings (excl ownership)

View all

8-K

Johnson & Johnson reports Q4 and Full-Year 2025 results

22 Oct 25

Johnson & Johnson reports Q3 2025 results; raises 2025 sales outlook

14 Oct 25

8-K

Departure of Directors or Certain Officers

8 Sep 25

N-PX

Annual report of proxy voting record

24 Jul 25

Johnson & Johnson reports Q2 2025 results; raises 2025 outlook

16 Jul 25

8-K

Johnson & Johnson Elects Daniel Pinto, President, JPMorganChase to its Board of Directors

10 Jun 25

Conflict minerals disclosure

28 May 25

8-K

Departure of Directors or Certain Officers

30 Apr 25

Latest ownership filings

View all

Elizabeth Forminard

6 Feb 26

144

Notice of proposed sale of securities

5 Feb 26

SCHEDULE 13G/A

Beneficial ownership report (amended)

Notice of proposed sale of securities

Financial summary

Financial statements Chart JNJ financial data

Quarter (USD)	Sep 25	Jun 25	Mar 25	Dec 24
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 24	Dec 23	Jan 23	Jan 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	18.23 bn	18.23 bn	18.23 bn	18.23 bn	18.23 bn	18.23 bn
Cash burn (monthly)	115.33 mm	145.75 mm	(no burn)	(no burn)	(no burn)	(no burn)
Cash used (since last report)	501.40 mm	633.63 mm	n/a	n/a	n/a	n/a
Cash remaining	17.73 bn	17.60 bn	n/a	n/a	n/a	n/a
Runway (months of cash)	153.7	120.7	n/a	n/a	n/a	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2025

JNJ institutional ownership history Ownership history

71.7% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	4133	4051	+2.0%
Opened positions	297	173	+71.7%
Closed positions	215	244	-11.9%
Increased positions	1663	1606	+3.5%
Reduced positions	1772	1869	-5.2%

13F shares	Current	Prev Q	Change
Total value	310.89 tn	258.15 tn	+20.4%
Total shares	1.73 bn	1.75 bn	-1.3%
Total puts	16.02 mm	14.03 mm	+14.2%
Total calls	19.76 mm	17.71 mm	+11.6%
Total put/call ratio	0.8	0.8	+2.4%

Largest owners	Shares	Value	Change
Vanguard	236.62 mm	$43.87 tn	-0.2%
BLK BlackRock	207.26 mm	$38.43 tn	+1.7%
STT State Street	132.21 mm	$24.51 tn	-0.4%
JPM JPMorgan Chase & Co.	58.64 mm	$10.87 tn	+4.5%
Geode Capital Management	56.22 mm	$10.39 tn	-7.2%
MS Morgan Stanley	48.23 mm	$8.94 tn	+2.7%
State Farm Mutual Automobile Insurance	31.59 mm	$5.86 tn	-0.3%
NTRS Northern Trust	29.97 mm	$5.56 tn	-1.2%
BAC Bank of America	28.42 mm	$5.27 tn	+3.3%
Wellington Management	25.83 mm	$4.79 tn	+3.8%

Largest transactions	Shares	Bought/sold	Change
Norges Bank	0.00	-31.93 mm	EXIT
GQG Partners	6.04 mm	+5.99 mm	+12137.4%
Geode Capital Management	56.22 mm	-4.39 mm	-7.2%
Ubs Global Asset Management Americas	15.90 mm	-3.78 mm	-19.2%
BLK BlackRock	207.26 mm	+3.41 mm	+1.7%
Flossbach Von Storch	3.00 mm	-3.35 mm	-52.8%
Capital International Investors	3.87 mm	+3.27 mm	+545.6%
Pacer Advisors	495.16 k	-2.63 mm	-84.2%
JPM JPMorgan Chase & Co.	58.64 mm	+2.54 mm	+4.5%
Kingstone Capital Partners Texas	0.00	-2.48 mm	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

JNJ insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
5 Feb 26	Elizabeth Forminard	Common Stock	Payment of exercise	Dispose F	No	No	237.9	6,226	1.48 mm	15,548
5 Feb 26	Elizabeth Forminard	Common Stock	Option exercise	Acquire M	No	No	129.51	8,921	1.16 mm	21,774
5 Feb 26	Elizabeth Forminard	Employee Stock Options Common Stock	Option exercise	Dispose M	No	No	129.51	8,921	1.16 mm	0
26 Jan 26	Duato Joaquin	Common Stock	Sell	Dispose S	Yes	No	221.484	48,782	10.80 mm	30,852
26 Jan 26	Duato Joaquin	Common Stock	Sell	Dispose S	Yes	No	220.986	51,218	11.32 mm	79,634
9 Dec 25	Pinto Daniel E	Deferred Share Units Common Stock	Grant	Acquire A	No	No	202.12	154.611	31.25 k	331.233
9 Dec 25	Marillyn A Hewson	Deferred Share Units Common Stock	Grant	Acquire A	No	No	202.12	247.378	50.00 k	14,153.119
9 Dec 25	Woods Eugene A.	Deferred Share Units Common Stock	Grant	Acquire A	No	No	202.12	185.533	37.50 k	5,058.068

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.